세계의 임상 검사 서비스 시장 : 전략과 동향, 예측 - 분석 유형별, 장소별, 제품별, 국가별: 상황 분석, 주요 컨설턴트 가이드 첨부(2025-2029년)

Global Clinical Medical Laboratory Services Market. Strategy & Trends with Forecasts by Assay Type, by Place, by Product, and by Country. Situation Analysis with Executive & Consultant Guides. 2025 to 2029

US $ 6,995 ￦ 9,725,000

PDF (Single User License)

PDF 보고서를 1명(One device)만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,495 ￦ 14,591,000

PDF (Five User License)

PDF 보고서를 동일 사업장의 5명(Five devices)까지 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 13,995 ￦ 19,457,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

임상 검사는 COVID의 과제에 직면했지만, 유행학의 종식은 진단에 대한 새로운 접근법을 만들어 냈습니다. 진단학은 급성장을 견인하고 있습니다.

임상검사는 생명공학, 특히 유전체학의 폭발적인 발전으로부터 직접 혜택을 받는 입장에 있습니다.

이 보고서는 세계의 임상 검사 서비스 시장에 대해 조사했으며, 시장 개요와 함께 분석 유형별, 위치별, 제품별, 국가별 동향 및 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 시장

제2장 소개와 시장 정의

• 임상검사의 새로운 수요
• 기회의 정의
• 조사 방법
• 관점: 헬스케어와 IVD 업계

제3장 시장 개요

• 시장 진입기관
  • 학술연구기관
  • 진단 시험 개발자
  • 계장 공급자
  • 약품 및 시약 제조업체
  • 병리 공급자
  • 독립계 임상 실험실
  • 공공의 국립/지역 연구소
  • 병원 검사실
  • 임상 실험실
  • 감사기관
  • 인증기관
• 세분화- 다양한 접근
• 임상 검사 업계의 구조
• 국가와 지역의 다양성

제4장 변화하는 시장을 추진하는 동향

• 성장 추진의 많은 측면
• 시장 축소의 요인
• 자동화와 연구실의 동향

제5장 임상 검사 서비스의 최근 동향

제6장 주요 기업 프로파일

• Acibadem Labmed Laboratory
• ACM Medical Laboratory
• Adicon Clinical Laboratories
• American Bio-Clinical Laboratories, Int'l
• ARUP Laboratories
• Ascend Clinical
• Assurance Scientific Laboratories
• Bio-Reference Laboratories
• Bioscientia Institut fur Medizinische Diagnostik GmbH
• BP Healthcare Group
• Clinical Reference Laboratory
• Clongen Laboratories
• CompuNet Clinical Laboratories
• Diagnosticos da America
• DIAN Diagnostics Co., Ltd.
• Enzo Biochem
• Eone Laboratories
• Eurofins Scientific
• Exagen Diagnostics
• Genzyme Corporation
• Gribbles Pathology
• Guangzhou Kingmed Diagnostics Group Co., Ltd.
• Integrated Regional Laboratories
• KDL Group
• Laboratory Corporation of America
• Lifelabs
• Mayo Clinic Laboratories
• Mid America Clinical Laboratories
• MNG Labs
• Myriad Genetics/Myriad RBM
• NeoGenomics
• OncoDNA
• Pathology, Inc.
• ProPhase Labs
• Psychemedics Corporation
• Quest Diagnostics
• RDL Reference Laboratory
• Sonic Healthcare
• Sophia Genetics
• Spectra Laboratories
• Synlab
• Sysmex Inostics
• Unilabs
• Werfen

제7장 세계의 임상 검사 시장

• 세계 시장 개요, 국가별
• 세계 시장 개요, 분석 유형별
• 세계 시장 개요, 장소별
• 세계 시장 개요, 제품별

제8장 세계의 임상검사 진단 시장 - 분석 유형별

• 화학
• 미생물학
• 혈액학
• 해부병리학
• 분자진단
• 난치성 검사

제9장 세계의 임상검사 진단시장- 장소별

• 입원 병동
• 외래병원
• 독립연구소
• 병원 검사실
• 기타

제10장 세계의 임상 검사 진단 시장- 제품별

• 기기
• 시약
• 인건비
• 간접비
• 기타

제11장 임상검사실의 미래

제12장 부록

JHS

영문 목차

영문목차

Report Overview:

The Clinical Laboratory rose to the COVID challenge, but the end of the pandemic has created a new approach to diagnostics. Point of Care and Self Testing are threatening long term demand for clinical lab services but Molecular Diagnostics is driving runaway growth. Understand the opportunities and the threats in this comprehensive report.

The fundamentals are still here. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations.

The report provides data that analysts and planners can use.

The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Table of Contents

1. Market Guides

• 1.1. Strategic Situation Analysis
• 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
• 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

• 2.1. The New Demand for Clinical Testing
• 2.2. Defining the Opportunity
  • 2.2.1. Revenue Market Size
• 2.3. Methodology
  • 2.3.1. Methodology
  • 2.3.2. Sources
  • 2.3.3. Authors
• 2.4. Perspective: Healthcare and the IVD Industry
  • 2.4.1. Global Healthcare Spending
  • 2.4.2. Spending on Diagnostics
  • 2.4.3. Important Role of Insurance for Diagnostics

3. Overview of a Dynamic Market

• 3.1. Players in a Dynamic Market
  • 3.1.1. Academic Research Lab
  • 3.1.2. Diagnostic Test Developer
  • 3.1.3. Instrumentation Supplier
  • 3.1.4. Chemical/Reagent Supplier
  • 3.1.5. Pathology Supplier
  • 3.1.6. Independent Clinical Laboratory
  • 3.1.7. Public National/regional Laboratory
  • 3.1.8. Hospital Laboratory
  • 3.1.9. Physicians Office Lab (POLS)
  • 3.1.10. Audit Body
  • 3.1.11. Certification Body
• 3.2. Segmentation - Different Approaches
  • 3.2.1. Traditional Market Segmentation
  • 3.2.2. Laboratory Focus and Segmentation
• 3.3. Structure of Clinical Testing Industry
  • 3.3.1. The Hospital Lab - Share of the Pie
  • 3.3.2. Key Role for Economies of Scale
  • 3.3.3. Physician Office Lab's are Still Here
  • 3.3.4. Physician's and POCT - Reviving Patient Service in China
• 3.4. National and Regional Diversity

4. Trends Driving a Changing Market

• 4.1. Growth Is Pushed from Many Sides
  • 4.1.1. Demographic Impacts on Consumption
  • 4.1.2. COVID Related Impacts
  • 4.1.3. Point of Care Testing Makes a Difference
  • 4.1.4. Alternative Medicine Effect
  • 4.1.5. Esoterics
  • 4.1.6. A New Laboratory Discipline
• 4.2. Factors at Work to Shrink the Market
  • 4.2.1. Where are Costs Going?
  • 4.2.2. Population Effects
  • 4.2.3. Management Practices
  • 4.2.4. Wellness
  • 4.2.5. Cannabilization
  • 4.2.6. Point of Care
• 4.3. Automation and Laboratory Trends
  • 4.3.1. Traditional Automation and Centralization
  • 4.3.2. The New Automation, Decentralization and Point Of Care
  • 4.3.3. Instruments Key to Market Share
  • 4.3.4. Bioinformatics Plays a Role
  • 4.3.5. PCR Takes Command
  • 4.3.6. Next Generation Sequencing Fuels a Revolution
  • 4.3.7. NGS Impact on Pricing
  • 4.3.8. Whole Genome Sequencing, A Brave New World
  • 4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
  • 4.3.10. Shifting Role of Diagnostics

5. Clinical Laboratory Services Recent Developments

• 5.1. Recent Developments - Importance and How to Use This Section
  • 5.1.1. Importance of These Developments
  • 5.1.2. How to Use This Section
• 5.2. Siemens Healthineers Reach New Level of Automation
• 5.3. Clinical Laboratory Prostate Cancer Screening Concerns
• 5.4. Clinical Labs Prepare for AI
• 5.5. Self-Testing and AI to Change Clinical Labs
• 5.6. Atalan Sees Potential in Hospital Outreach Business
• 5.7. Challenge Bringing Routine Testing to Point of Care
• 5.8. Natera Cites Test Volume Growth, Rosy Reimbursement
• 5.9. Patients Becoming Stakeholders in Infectious Disease Testing
• 5.10. MedGenome Acquires Prognosis Laboratories
• 5.11. Brooks Automation acquires Aim Lab
• 5.12. Avalon GloboCare Announces Strategic Investment in Laboratory Services MSO
• 5.13. Mayo Clinic Laboratories and Helix to provide Biopharma Services
• 5.14. CompuGroup Medical acquires Medicus Laboratory Information Systems
• 5.15. Quest Diagnostics acquires Summa Health outreach lab
• 5.16. Q2 Solutions Launches Self-Collection Safety Lab Panel
• 5.17. Bionano Genomics Announces Launch of Bionano Laboratories
• 5.18. Labcorp to Spin Off Clinical Development Business
• 5.19. Value-Based Care Growing More Profitable for Labs
• 5.20. Lucid Diagnostics Reports Revenue Growth
• 5.21. NGS Cancer Testing Decision Appeases Industry
• 5.22. Clinical Labs Make Strong Showing in 2021
• 5.23. Seegene to Enter Syndromic MDx Space
• 5.24. EKF Diagnostics Acquires Advanced Diagnostic Laboratory
• 5.25. Molecular Health, EDGC Ink Liquid Biopsy Partnership
• 5.26. ProPhase Labs Acquires Nebula Genomics for $14.6M
• 5.27. Karius Cell-Free DNA Method to Detect Infection Validated
• 5.28. EDGC Enters Liquid Biopsy Space With Cf DNA
• 5.29. TruDiagnostic Receives CLIA Certification for Kentucky Laboratory
• 5.30. Enzo Biochem Q2 Revenues Up 62 Percent
• 5.31. Thermo Fisher Gets CE Mark for High-Throughput COVID-19 Assay
• 5.32. FDA Issues Alert - False Negatives due to SARS-CoV-2 Mutations
• 5.33. Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19?
• 5.34. Chinese Infectious Dx Firm Vision Medicals Completes Series B Financing
• 5.35. Cooperative Aims to Expand Clinical, Commercial NGS Access

6. Profiles of Key Companies

• 6.1. Acibadem Labmed Laboratory
• 6.2. ACM Medical Laboratory
• 6.3. Adicon Clinical Laboratories
• 6.4. American Bio-Clinical Laboratories, Int'l
• 6.5. ARUP Laboratories
• 6.6. Ascend Clinical
• 6.7. Assurance Scientific Laboratories
• 6.8. Bio-Reference Laboratories
• 6.9. Bioscientia Institut fur Medizinische Diagnostik GmbH
• 6.10. BP Healthcare Group
• 6.11. Clinical Reference Laboratory
• 6.12. Clongen Laboratories
• 6.13. CompuNet Clinical Laboratories
• 6.14. Diagnosticos da America
• 6.15. DIAN Diagnostics Co., Ltd.
• 6.16. Enzo Biochem
• 6.17. Eone Laboratories
• 6.18. Eurofins Scientific
• 6.19. Exagen Diagnostics
• 6.20. Genzyme Corporation
• 6.21. Gribbles Pathology
• 6.22. Guangzhou Kingmed Diagnostics Group Co., Ltd.
• 6.23. Integrated Regional Laboratories
• 6.24. KDL Group
• 6.25. Laboratory Corporation of America
• 6.26. Lifelabs
• 6.27. Mayo Clinic Laboratories
• 6.28. Mid America Clinical Laboratories
• 6.29. MNG Labs
• 6.30. Myriad Genetics/Myriad RBM
• 6.31. NeoGenomics
• 6.32. OncoDNA
• 6.33. Pathology, Inc.
• 6.34. ProPhase Labs
• 6.35. Psychemedics Corporation
• 6.36. Quest Diagnostics
• 6.37. RDL Reference Laboratory
• 6.38. Sonic Healthcare
• 6.39. Sophia Genetics
• 6.40. Spectra Laboratories
• 6.41. Synlab
• 6.42. Sysmex Inostics
• 6.43. Unilabs
• 6.44. Werfen

7. The Global Market for Clinical Laboratory Testing

• 7.1. Global Market Overview by Country
  • 7.1.1. Table - Global Market by Country
  • 7.1.2. Chart - Global Market by Country
• 7.2. Global Market by Assay Type - Overview
  • 7.2.1. Table - Global Market by Assay Type
  • 7.2.2. Chart - Global Market by Assay Type - Base/Final Year Comparison
  • 7.2.3. Chart - Global Market by Assay Type - Base Year
  • 7.2.4. Chart - Global Market by Assay Type - End Year
  • 7.2.5. Chart - Global Market by Assay Type - Share by Year
  • 7.2.6. Chart - Global Market by Assay Type - Segments Growth
• 7.3. Global Market by Place - Overview
  • 7.3.1. Table - Global Market by Place
  • 7.3.2. Chart - Global Market by Place - Base/Final Year Comparison
  • 7.3.3. Chart - Global Market by Place - Base Year
  • 7.3.4. Chart - Global Market by Place - End Year
  • 7.3.5. Chart - Global Market by Place - Share by Year
  • 7.3.6. Chart - Global Market by Place - Segments Growth
• 7.4. Global Market by Product - Overview
  • 7.4.1. Table - Global Market by Product
  • 7.4.2. Chart - Global Market by Product - Base/Final Year Comparison
  • 7.4.3. Chart - Global Market by Product - Base Year
  • 7.4.4. Chart - Global Market by Product - End Year
  • 7.4.5. Chart - Global Market by Product - Share by Year
  • 7.4.6. Chart - Global Market by Product - Segments Growth

8. Global Clinical Laboratory Diagnostic Markets - By Assay Type

• 8.1. Chemistry
  • 8.1.1. Table Chemistry - by Country
  • 8.1.2. Chart - Chemistry Growth
• 8.2. Microbiology
  • 8.2.1. Table Microbiology - by Country
  • 8.2.2. Chart - Microbiology Growth
• 8.3. Hematology
  • 8.3.1. Table Hematology - by Country
  • 8.3.2. Chart - Hematology Growth
• 8.4. Anatomic Pathology
  • 8.4.1. Table Anatomic Pathology - by Country
  • 8.4.2. Chart - Anatomic Pathology Growth
• 8.5. Molecular Diagnostics
  • 8.5.1. Table Molecular Diagnostics - by Country
  • 8.5.2. Chart - Molecular Diagnostics Growth
• 8.6. Esoteric
  • 8.6.1. Table Esoteric - by Country
  • 8.6.2. Chart - Esoteric Growth

9. Global Clinical Laboratory Diagnostic Markets - By Place

• 9.1. In Patient Hospital
  • 9.1.1. Table In Patient Hospital - by Country
  • 9.1.2. Chart - In Patient Hospital Growth
• 9.2. Out Patient Hospital
  • 9.2.1. Table Out Patient Hospital - by Country
  • 9.2.2. Chart - Out Patient Hospital Growth
• 9.3. Independent Laboratory
  • 9.3.1. Table Independent Laboratory - by Country
  • 9.3.2. Chart - Independent Laboratory Growth
• 9.4. Physicians Office Laboratory
  • 9.4.1. Table Physicians Office Laboratory - by Country
  • 9.4.2. Chart - Physicians Office Laboratory Growth
• 9.5. Other Laboratory
  • 9.5.1. Table Other Laboratory - by Country
  • 9.5.2. Chart - Other Laboratory Growth

10. Global Clinical Laboratory Diagnostic Markets - By Product

• 10.1. Instruments
  • 10.1.1. Table Instruments - by Country
  • 10.1.2. Chart - Instruments Growth
• 10.2. Reagents
  • 10.2.1. Table Reagents - by Country
  • 10.2.2. Chart - Reagents Growth
• 10.3. Labour
  • 10.3.1. Table Labour - by Country
  • 10.3.2. Chart - Labour Growth
• 10.4. Overhead
  • 10.4.1. Table Overhead - by Country
  • 10.4.2. Chart - Overhead Growth
• 10.5. Other Product
  • 10.5.1. Table Other Product - by Country
  • 10.5.2. Chart - Other Product Growth

11. The Future of the Clinical Laboratory

12. Appendices

• 12.1. United States Medicare System: Clinical Laboratory Fees Schedule
• 12.2. The Most Used IVD Assays
• 12.3. The Highest Grossing Assays

관련자료